Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Plos One
|
December 8, 2022
Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer
Jason Driver Tucker, Ravi Doddapaneni, Pei Juan Lu, et al.
Molecular Therapy. Methods & Clinical Development
|
January 29, 2020
ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
Marcela P Cataldi, Anthony Blaeser, Peijuan Lu, et al.
Molecular Therapy. Methods & Clinical Development
|
May 9, 2017
Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene
Charles Harvey Vannoy, Will Xiao, Peijuan Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 28, 2010
The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy
Qi-Long Lu, Toshifumi Yokota, Shin'ichi Takeda, et al.
Radiology
|
August 6, 2005
Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents
Xinghua Wang, Hai-Dong Liang, Baowei Dong, et al.
Annals of the New York Academy of Sciences
|
October 3, 2009
Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy
Hong M Moulton, Bo Wu, Natee Jearawiriyapaisarn, et al.
Human Gene Therapy
|
January 11, 2014
Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked polyethylenimine as antisense morpholino oligomer delivery vehicle in cell culture and dystrophic mdx mice
Mingxing Wang, Bo Wu, Jay D Tucker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 12, 2009
Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice
Bo Wu, Yongfu Li, Paul A Morcos, et al.
Archives of Neurology
|
January 14, 2009
A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground
Toshifumi Yokota, Shin'ichi Takeda, Qi-Long Lu, et al.
Plos One
|
May 26, 2011
Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development
Bo Wu, Ehsan Benrashid, Peijuan Lu, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Plos One
|
December 8, 2022
Ribitol alters multiple metabolic pathways of central carbon metabolism with enhanced glycolysis: A metabolomics and transcriptomics profiling of breast cancer
Jason Driver Tucker, Ravi Doddapaneni, Pei Juan Lu, et al.
Molecular Therapy. Methods & Clinical Development
|
January 29, 2020
ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
Marcela P Cataldi, Anthony Blaeser, Peijuan Lu, et al.
Molecular Therapy. Methods & Clinical Development
|
May 9, 2017
Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene
Charles Harvey Vannoy, Will Xiao, Peijuan Lu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 28, 2010
The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy
Qi-Long Lu, Toshifumi Yokota, Shin'ichi Takeda, et al.
Radiology
|
August 6, 2005
Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: comparison between commercially available microbubble contrast agents
Xinghua Wang, Hai-Dong Liang, Baowei Dong, et al.
Annals of the New York Academy of Sciences
|
October 3, 2009
Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy
Hong M Moulton, Bo Wu, Natee Jearawiriyapaisarn, et al.
Human Gene Therapy
|
January 11, 2014
Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked polyethylenimine as antisense morpholino oligomer delivery vehicle in cell culture and dystrophic mdx mice
Mingxing Wang, Bo Wu, Jay D Tucker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 12, 2009
Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice
Bo Wu, Yongfu Li, Paul A Morcos, et al.
Archives of Neurology
|
January 14, 2009
A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground
Toshifumi Yokota, Shin'ichi Takeda, Qi-Long Lu, et al.
Plos One
|
May 26, 2011
Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development
Bo Wu, Ehsan Benrashid, Peijuan Lu, et al.
Page
of 5